This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In this Q&A, Dr Imran Khan, PhD, Vice President Medical Affairs, Hematology at Johnson & Johnson Innovative Medicine, highlights the current landscape of CAR T therapies such as CARVYKTI and touches on the future direction of the sector. Most recently, Imran has served as MedicalScience Liaison (MSL) Head, Oncology U.S.
However, proper healthcare marketing has made prospects more aware of company insurance and other medical schemes. Although technology and medicalsciences have come a long way, marketing healthcare services was difficult until 2017. Importance of Marketing Strategies in Healthcare Systems.
Kaitlin Anstett Senior Medical Advisor Kaitlin Anstett is currently a Senior Medical Advisor at Theratechnologies, working with their HIV/AIDS portfolio. She graduated from the University of Toronto in 2013, and completed her PhD in Microbiology and Immunology at McGill University in 2017.
In recent years, there has been an increased focus on real world evidence to advance medicalscience and improve patient quality of life. The suitability of RWD, the FDA said in a 2017 guidance report , depends on its relevance (whether data directly addresses intended use) and reliability (completeness, accuracy and timeliness) [2].
For indexing in Web of Science, Early Access is defined as ‘Version of Record’ content that is published online prior to final assignment in a completed volume/issue. The massive and rapid response of the scholarly community to COVID-19 extends far beyond medical care or medicalsciences, and its ripples will continue for years, or decades.
In 2017, majority of health plans — 55% of health plans in the sample studied made the originator product the sole preferred product, said Chambers, who also leads the Tufts Medical Center Specialty Drug Evidence and Coverage (SPEC) Database. What Exhibit 2 is showing is the inconsistency across health plans, he said.
According to some estimates, between 2017 and 2047, the number of individuals living with stroke will increase by 27% in the EU. Second, adopting a single sourcing strategy creates more risk, explains Liz Breen, PhD, professor at the University of Bradford’s School of Pharmacy and MedicalSciences.
The first human trial done in Israel proved very successful (2017-2018, finalized during COVID), and published in the Red Journal , the official journal of the American Society for Radiation Oncology), involving many patients whose cancer recurred after treatment or whose options were exhausted.
Mehrdad was an adjunct clinical faculty member in the Division of Medical Oncology at Stanford University after completing his fellowships in haematology and medical oncology at Stanford and prior to that completed his internal medicine residency at University of California-Irvine. 2017; 1(20):1739–48. 2022; 21(1).
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content